retatrutide weight loss efficacy clinical trial results 2024 2025 retatrutide study What Are the New Medications? Survodutide vs. Retatrutide for Weight – Retatrutide Helped Adults With Diabetes

Patients experience a safe and effective pathway to achieving their weight management goals

Whittle IR, Smith C, Navoo P, Collie D

Sessions are relatively quick, allowing patients to resume their daily activities with minimal disruption

Introduction The presence of type 2 diabetes or maternal obesity during pregnancy increases the risk of adverse pregnancy outcomes and birth defects ( In a non-pregnant patient with type 2 diabetes, a GLP-1 agonist or SGLT2 inhibitor can be prescribed if adequate glycemic control is not achieved with metformin, sulphonylureas or (basal) insulin, or if weight reduction, hypoglycemia prevention or reduction of cardiovascular risk is the treatment goal ( Despite the fact that these novel glucose lowering medications have seen wide uptake in clinical practice, information regarding the safety of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation is exceedingly scarce

FAQs How does GLP-1 work for weight loss

Once your fat increases, it starts acting like an active organ, so to speak, constantly sending hormones and signals to the rest of the body